Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study

Front Med (Lausanne). 2022 Dec 19:9:1096867. doi: 10.3389/fmed.2022.1096867. eCollection 2022.

Authors

Michael Kasperkiewicz¹, Stefan Tukaj²

Affiliations

¹ Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
² Department of Molecular Biology, Faculty of Biology, University of Gdańsk, Gdańsk, Poland.

No abstract available

Keywords: COVID-19; SARS-CoV-2; autoimmune bullous diseases; bullous pemphigoid; vaccination.

Publication types

Comment